Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI

Prostate cancer (PCa) is the most frequent male malignancy and the assessment of PCa aggressiveness, for which a biopsy is required, is fundamental for patient management. Currently, multiparametric (mp) MRI is strongly recommended before biopsy. Quantitative assessment of mpMRI might provide the ra...

Full description

Bibliographic Details
Main Authors: Elena Bertelli, Laura Mercatelli, Chiara Marzi, Eva Pachetti, Michela Baccini, Andrea Barucci, Sara Colantonio, Luca Gherardini, Lorenzo Lattavo, Maria Antonietta Pascali, Simone Agostini, Vittorio Miele
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.802964/full
_version_ 1830209238344925184
author Elena Bertelli
Laura Mercatelli
Chiara Marzi
Eva Pachetti
Eva Pachetti
Michela Baccini
Michela Baccini
Andrea Barucci
Sara Colantonio
Luca Gherardini
Lorenzo Lattavo
Maria Antonietta Pascali
Simone Agostini
Vittorio Miele
author_facet Elena Bertelli
Laura Mercatelli
Chiara Marzi
Eva Pachetti
Eva Pachetti
Michela Baccini
Michela Baccini
Andrea Barucci
Sara Colantonio
Luca Gherardini
Lorenzo Lattavo
Maria Antonietta Pascali
Simone Agostini
Vittorio Miele
author_sort Elena Bertelli
collection DOAJ
description Prostate cancer (PCa) is the most frequent male malignancy and the assessment of PCa aggressiveness, for which a biopsy is required, is fundamental for patient management. Currently, multiparametric (mp) MRI is strongly recommended before biopsy. Quantitative assessment of mpMRI might provide the radiologist with an objective and noninvasive tool for supporting the decision-making in clinical practice and decreasing intra- and inter-reader variability. In this view, high dimensional radiomics features and Machine Learning (ML) techniques, along with Deep Learning (DL) methods working on raw images directly, could assist the radiologist in the clinical workflow. The aim of this study was to develop and validate ML/DL frameworks on mpMRI data to characterize PCas according to their aggressiveness. We optimized several ML/DL frameworks on T2w, ADC and T2w+ADC data, using a patient-based nested validation scheme. The dataset was composed of 112 patients (132 peripheral lesions with Prostate Imaging Reporting and Data System (PI-RADS) score ≥ 3) acquired following both PI-RADS 2.0 and 2.1 guidelines. Firstly, ML/DL frameworks trained and validated on PI-RADS 2.0 data were tested on both PI-RADS 2.0 and 2.1 data. Then, we trained, validated and tested ML/DL frameworks on a multi PI-RADS dataset. We reported the performances in terms of Area Under the Receiver Operating curve (AUROC), specificity and sensitivity. The ML/DL frameworks trained on T2w data achieved the overall best performance. Notably, ML and DL frameworks trained and validated on PI-RADS 2.0 data obtained median AUROC values equal to 0.750 and 0.875, respectively, on unseen PI-RADS 2.0 test set. Similarly, ML/DL frameworks trained and validated on multi PI-RADS T2w data showed median AUROC values equal to 0.795 and 0.750, respectively, on unseen multi PI-RADS test set. Conversely, all the ML/DL frameworks trained and validated on PI-RADS 2.0 data, achieved AUROC values no better than the chance level when tested on PI-RADS 2.1 data. Both ML/DL techniques applied on mpMRI seem to be a valid aid in predicting PCa aggressiveness. In particular, ML/DL frameworks fed with T2w images data (objective, fast and non-invasive) show good performances and might support decision-making in patient diagnostic and therapeutic management, reducing intra- and inter-reader variability.
first_indexed 2024-12-18T05:03:45Z
format Article
id doaj.art-d19f9ec97f514b49a39787fa70188101
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-18T05:03:45Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-d19f9ec97f514b49a39787fa701881012022-12-21T21:20:04ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-01-011110.3389/fonc.2021.802964802964Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRIElena Bertelli0Laura Mercatelli1Chiara Marzi2Eva Pachetti3Eva Pachetti4Michela Baccini5Michela Baccini6Andrea Barucci7Sara Colantonio8Luca Gherardini9Lorenzo Lattavo10Maria Antonietta Pascali11Simone Agostini12Vittorio Miele13Department of Radiology, Careggi University Hospital, Florence, ItalyDepartment of Radiology, Careggi University Hospital, Florence, Italy“Nello Carrara” Institute of Applied Physics (IFAC), National Research Council of Italy (CNR), Sesto Fiorentino, Italy“Alessandro Faedo” Institute of Information Science and Technologies (ISTI), National Research Council of Italy (CNR), Pisa, ItalyDepartment of Information Engineering (DII), University of Pisa, Pisa, Italy“Giuseppe Parenti” Department of Statistics, Computer Science, Applications(DiSIA), University of Florence, Florence, ItalyFlorence Center for Data Science, University of Florence, Florence, Italy“Nello Carrara” Institute of Applied Physics (IFAC), National Research Council of Italy (CNR), Sesto Fiorentino, Italy“Alessandro Faedo” Institute of Information Science and Technologies (ISTI), National Research Council of Italy (CNR), Pisa, Italy“Giuseppe Parenti” Department of Statistics, Computer Science, Applications(DiSIA), University of Florence, Florence, ItalyDepartment of Radiology, Careggi University Hospital, Florence, Italy“Alessandro Faedo” Institute of Information Science and Technologies (ISTI), National Research Council of Italy (CNR), Pisa, ItalyDepartment of Radiology, Careggi University Hospital, Florence, ItalyDepartment of Radiology, Careggi University Hospital, Florence, ItalyProstate cancer (PCa) is the most frequent male malignancy and the assessment of PCa aggressiveness, for which a biopsy is required, is fundamental for patient management. Currently, multiparametric (mp) MRI is strongly recommended before biopsy. Quantitative assessment of mpMRI might provide the radiologist with an objective and noninvasive tool for supporting the decision-making in clinical practice and decreasing intra- and inter-reader variability. In this view, high dimensional radiomics features and Machine Learning (ML) techniques, along with Deep Learning (DL) methods working on raw images directly, could assist the radiologist in the clinical workflow. The aim of this study was to develop and validate ML/DL frameworks on mpMRI data to characterize PCas according to their aggressiveness. We optimized several ML/DL frameworks on T2w, ADC and T2w+ADC data, using a patient-based nested validation scheme. The dataset was composed of 112 patients (132 peripheral lesions with Prostate Imaging Reporting and Data System (PI-RADS) score ≥ 3) acquired following both PI-RADS 2.0 and 2.1 guidelines. Firstly, ML/DL frameworks trained and validated on PI-RADS 2.0 data were tested on both PI-RADS 2.0 and 2.1 data. Then, we trained, validated and tested ML/DL frameworks on a multi PI-RADS dataset. We reported the performances in terms of Area Under the Receiver Operating curve (AUROC), specificity and sensitivity. The ML/DL frameworks trained on T2w data achieved the overall best performance. Notably, ML and DL frameworks trained and validated on PI-RADS 2.0 data obtained median AUROC values equal to 0.750 and 0.875, respectively, on unseen PI-RADS 2.0 test set. Similarly, ML/DL frameworks trained and validated on multi PI-RADS T2w data showed median AUROC values equal to 0.795 and 0.750, respectively, on unseen multi PI-RADS test set. Conversely, all the ML/DL frameworks trained and validated on PI-RADS 2.0 data, achieved AUROC values no better than the chance level when tested on PI-RADS 2.1 data. Both ML/DL techniques applied on mpMRI seem to be a valid aid in predicting PCa aggressiveness. In particular, ML/DL frameworks fed with T2w images data (objective, fast and non-invasive) show good performances and might support decision-making in patient diagnostic and therapeutic management, reducing intra- and inter-reader variability.https://www.frontiersin.org/articles/10.3389/fonc.2021.802964/fullprostate cancermpMRI prostate cancer aggressivenessdeep learningmachine learningradiomics
spellingShingle Elena Bertelli
Laura Mercatelli
Chiara Marzi
Eva Pachetti
Eva Pachetti
Michela Baccini
Michela Baccini
Andrea Barucci
Sara Colantonio
Luca Gherardini
Lorenzo Lattavo
Maria Antonietta Pascali
Simone Agostini
Vittorio Miele
Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
Frontiers in Oncology
prostate cancer
mpMRI prostate cancer aggressiveness
deep learning
machine learning
radiomics
title Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
title_full Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
title_fullStr Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
title_full_unstemmed Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
title_short Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
title_sort machine and deep learning prediction of prostate cancer aggressiveness using multiparametric mri
topic prostate cancer
mpMRI prostate cancer aggressiveness
deep learning
machine learning
radiomics
url https://www.frontiersin.org/articles/10.3389/fonc.2021.802964/full
work_keys_str_mv AT elenabertelli machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT lauramercatelli machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT chiaramarzi machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT evapachetti machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT evapachetti machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT michelabaccini machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT michelabaccini machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT andreabarucci machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT saracolantonio machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT lucagherardini machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT lorenzolattavo machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT mariaantoniettapascali machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT simoneagostini machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri
AT vittoriomiele machineanddeeplearningpredictionofprostatecanceraggressivenessusingmultiparametricmri